These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21689638)

  • 1. The role of the BH3-only protein Noxa in bone homeostasis.
    Idrus E; Nakashima T; Wang L; Hayashi M; Okamoto K; Kodama T; Tanaka N; Taniguchi T; Takayanagi H
    Biochem Biophys Res Commun; 2011 Jul; 410(3):620-5. PubMed ID: 21689638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
    Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
    Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
    Takayanagi H; Kim S; Matsuo K; Suzuki H; Suzuki T; Sato K; Yokochi T; Oda H; Nakamura K; Ida N; Wagner EF; Taniguchi T
    Nature; 2002 Apr; 416(6882):744-9. PubMed ID: 11961557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
    Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
    Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
    Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.
    Asagiri M; Sato K; Usami T; Ochi S; Nishina H; Yoshida H; Morita I; Wagner EF; Mak TW; Serfling E; Takayanagi H
    J Exp Med; 2005 Nov; 202(9):1261-9. PubMed ID: 16275763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
    Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
    J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.
    Hentunen TA; Reddy SV; Boyce BF; Devlin R; Park HR; Chung H; Selander KS; Dallas M; Kurihara N; Galson DL; Goldring SR; Koop BA; Windle JJ; Roodman GD
    J Clin Invest; 1998 Jul; 102(1):88-97. PubMed ID: 9649561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
    Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
    Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
    Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
    J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
    de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
    J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commitment and differentiation of stem cells to the osteoclast lineage.
    Hayashi S; Yamane T; Miyamoto A; Hemmi H; Tagaya H; Tanio Y; Kanda H; Yamazaki H; Kunisada T
    Biochem Cell Biol; 1998; 76(6):911-22. PubMed ID: 10392705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
    Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.